Open Mics with Dr. Stites: “Miraculous” New Treatment for Multiple Myeloma

แชร์
ฝัง
  • เผยแพร่เมื่อ 24 ม.ค. 2023
  • The University of Kansas Health System is treating a total of 54 COVID patients today, 69 Monday. Other significant numbers:
    23 with the active virus today, 34 Monday
    3 in ICU, 6 Monday
    3 on a ventilator, 4 Monday
    Key points from today’s guests:
    Dr. Joseph McGuirk, director, hematologic malignancies and cellular therapeutics, The University of Kansas Cancer Center
    Myeloma, in contrast to some of the lymphomas, has historically been considered an incurable disease. There are very small percentage of patients who are in remission for very long periods of time, 10-15 years and even beyond that.
    We need to change that dynamic and we're hopeful that these new immunotherapies are going to be not just a game changer, but a stunning game changer.
    These treatments are being optimized in our cancer center, and in research and laboratories across our nation.
    We're in the middle of a revolution, the likes of which we've never seen in cancer therapy and it’s on the shoulders of men and women who've worked in laboratories across the world community.
    Dr. Al-Ola Abdallah, multiple myeloma specialist, The University of Kansas Cancer Center
    One patient’s new treatment (Techlistimab) forces T cells to recognize myeloma cancer cells and attack them. And after multiple other treatments, with this new treatment, the patient’s scan showed a miraculous change after one week.
    It means going from weekly infusions to infusions every other week for the patient.
    The new Car T cell therapy is a first generation that has response rates of 97% and complete remissions of 65-80% depending on which study.
    This is an extraordinary development in cancer therapeutics using the immune system to kill these cancers so highly effectively.
    The importance of this treatment is not just to fight infection, but also to recognize abnormally behaving cells and attack and destroy them before they become full blown clinical cancer in our patients.
    Dr. Dana Hawkinson, director of infection and prevention control, The University of Kansas Health System
    A month out from the holidays and COVID, flu and RSV numbers are starting to decline, which is a good sign.
    In the future, there is a possibility of either yearly or twice yearly vaccinations for COVID that will be recommended.
    There could be some increasing seasonality to it like influenza, RSV and those other respiratory illnesses.
    COVID is really becoming a disease of the elderly, especially those over 75 but also those with comorbidities like diabetes, obesity, heart disease, kidney disease, lung disease, etc.
    Friday, January 27 is the next live broadcast of the Morning Medical Update. You’ll meet a breast cancer survivor who’s fighting a new battle. Her cancer is gone but now she’s trying to get her body back, ten years later.
    Visit our website, www.kansashealthsystem.com or findadoctor.kansashealthsystem.com.
  • วิทยาศาสตร์และเทคโนโลยี

ความคิดเห็น • 14

  • @thomasgallegos2832
    @thomasgallegos2832 7 หลายเดือนก่อน +2

    It's working for me. 9 months on November 14 th. 2023. I doing very well, Thanks !!

  • @amandamerrill5807
    @amandamerrill5807 ปีที่แล้ว +7

    My stepdad just met his end with MM. After 10+ years, and EVERY MM TREATMENT, the cancer finally spread to soft tissue about 6 months ago. He spent the last few months of his life in the most pain he’s ever had, both emotionally and physically.
    He tried this car-T therapy. It was the last he ever did. Ultimately, his kidneys were destroyed.

    • @thomasgallegos2832
      @thomasgallegos2832 7 หลายเดือนก่อน +1

      My condolences to you. May he be at peace. I can totally understand, sometimes I think how did I get here ? I'm grateful for more quality time lately 💜🙏

    • @Whatt787
      @Whatt787 3 หลายเดือนก่อน

      My father only lasted 2.5 years back in 1996 with MM

  • @rmcellig
    @rmcellig ปีที่แล้ว +9

    I'm in a phase 1/2 study for eronatamab from Pfizer. I'm in full remission after only 5 weeks.

    • @rmcellig
      @rmcellig 11 หลายเดือนก่อน

      @mickjay7397 I was running out of options. My hematologist thought the elranatomab study would be perfect for me because of the shape I was in. So far it's going well but once I relapse I don't think there will be any treatments left for me.

    • @rmcellig
      @rmcellig 11 หลายเดือนก่อน

      @mickjay7397 same here! Take care.

  • @Luckylady2224
    @Luckylady2224 ปีที่แล้ว +3

    It's an amazing drug. It's worked for us too!!!

  • @webversation
    @webversation ปีที่แล้ว +2

    Why no one talks about Ozone Therapy?

    • @samandkay26
      @samandkay26 ปีที่แล้ว

      What is ozone therapy?

    • @JesusSanchez-xu2is
      @JesusSanchez-xu2is 7 หลายเดือนก่อน +1

      ​@@samandkay26 it oxygenates the Blood. O3 Multi Pass. I did prior to my BMB. And they couldn't find it. Through normal tests. They had to to do a FISH panel to find it. I'm going through induction right now. Once it slows down I'll start up with Ozone therapy again.

    • @christinan005
      @christinan005 2 หลายเดือนก่อน

      Where u go for the therapy?

  • @pjrockturnal
    @pjrockturnal ปีที่แล้ว +2

    Excellent video and incredibly informative. Thank you so much for posting this. Amazing people.